Cystic Fibrosis: Advances in Treatment and Management

Since the last edition, cystic fibrosis has witnessed remarkable breakthroughs in treatment, including the development of targeted cystic fibrosis transmembrane conductance regulator (CFTR) protein modulators for most CFTR gene abnormalities. This new fifth edition provides a comprehensive update on the rapid clinical and scientific advances in improving prognosis, as well as the impact of COVID-19, which has transformed conventional models of care.

Advances in Basic Science and Clinical Management

The book covers the latest understanding of the biology of the CFTR gene and protein, leading to novel and beneficial therapies. It also explores all aspects of clinical management in high-, middle-, and low-income settings, drawing on global expertise and reflecting best evidence-based practice from experts conducting cutting-edge clinical and basic science research from around the world.

A Valuable Resource for Clinicians and Scientists

This authoritative text is designed to appeal to clinicians, including trainees, across the whole multidisciplinary team, as well as scientists and students. It follows an appealing organization of chapters, building fundamental knowledge before moving on to more complex or developing topics.

Key Features

• Integrates fundamental science and clinical aspects of cystic fibrosis
• Presents a comprehensive and up-to-date text
• Drawing on global expertise and reflecting best evidence-based practice
• An attractive read for clinicians, trainee doctors, and scientists

Product Details:

• Language: English
• Publication date: November 20, 2023
• Publisher: CRC Press; 5 edition
• ISBN-10: 1032202203
• ISBN-13: 978-1032202204

Stay updated with the latest advancements in cystic fibrosis treatment and management. This book is a valuable resource for anyone looking to improve their understanding of this complex disease.